Family Information Management in the Intensive Care Unit (ICU-Families)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02931851 |
Recruitment Status :
Suspended
First Posted : October 13, 2016
Last Update Posted : January 5, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Relatives in intensive care units (ICU) are important partners in decision-making in the treatment of critically ill patients and provide a significant resource in the care and recovery of patients. Therefore, a professional, educational intervention targeting these caregivers may have fundamental benefits with little risk. As in other fields, information is searched in the internet, but this unselected information is often overwhelming and of little use in this context.
Symptoms of anxiety, stress and depression are common in affected relatives. The majority of family members report some level of anxiety, depression and stress, sometimes even resulting in post-traumatic stress disorder (PTSD). Importantly, an association between lack of information and post-traumatic stress disorder PTSD has been reported. The large number of potentially affected families poses a particular challenge to healthcare and may cause substantial secondary costs to national economy.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Extended Family | Other: ICU Families Website Other: Placebo | Not Applicable |

Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 75 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Family Information Management in the Intensive Care Unit: A Randomized Controlled Trial |
Actual Study Start Date : | May 1, 2015 |
Estimated Primary Completion Date : | March 2021 |
Estimated Study Completion Date : | July 2021 |
Arm | Intervention/treatment |
---|---|
Placebo Comparator: Placebo
Standard Information
|
Other: Placebo
Standard Information provided online |
Active Comparator: Intervention
Professionally developed website for relatives of ICU patients
|
Other: ICU Families Website
Professionally developed website for relatives of ICU patients |
- Subjective distress [ Time Frame: 30 Days ]Impact of Event Score (IES: symptoms of post traumatic stress disorder)
- Levels of anxiety and depression [ Time Frame: 30 days ]Measured by Hospital Anxiety and Depression Score (HADS)
- Subjective usefulness of the website for relatives [ Time Frame: 30 days ]Subjective Evaluation
- Length of stay [ Time Frame: 90 days ]ICU and Hospital length of stay of the index patients
- Readmissions [ Time Frame: 90 days ]number of readmissions of the index patients
- Mortality [ Time Frame: 90 days ]mortality of the index patients
- User-statistics [ Time Frame: 30 days ]user statistics for the website

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 100 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- anticipated further ICU stay ≥3 days (index patient)
Exclusion Criteria:
- lack of Basic Information Technology (IT) user knowledge or German language skills
- DNR (Do not resuscitate) orders (index patient)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02931851
Austria | |
Medical University of Graz | |
Graz, Austria, 8036 | |
Medical University of Vienna | |
Vienna, Austria | |
Switzerland | |
University of Berne - Inselspital | |
Bern, Switzerland |
Principal Investigator: | Karin Amrein, MD, MSc | Medical University of Graz |
Responsible Party: | Medical University of Graz |
ClinicalTrials.gov Identifier: | NCT02931851 |
Other Study ID Numbers: |
ICU-Families 1.0 |
First Posted: | October 13, 2016 Key Record Dates |
Last Update Posted: | January 5, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Undecided |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |